Are polymorphisms in the VKORC1 gene strongly associated with warfarin dosage requirements in patients receiving anticoagulation?
These results are of considerable clinical interest and confirm recently published results regarding the role of these two genes in modifying warfarin metabolism and maintenance dosage. The consistent findings regarding the role of VKORC1 and CYP2C9 in warfarin metabolism and maintenance dosage represent a clinically useful proof of principal for the use of pharmacogenomic information in medicine and may lead to improved understanding of warfarin's actions.
In this series, all patients underwent successful delayed reconstruction following gastric devascularization without anastomotic leak. The absence of anastomotic leak in the delay group suggests that delayed conduit preparation can be accomplished safely while potentially reducing the morbidity associated with esophagectomy, but larger prospective studies are required to prove this definitively.